News Tag: Corporate Information

• The consumer version of Dosell is a subscription service that will be the only medication dispensing robot in Sweden that offers the more than 200,000 people in Sweden who receive their medications in dose-packed sachets the opportunity to subscribe to a medication dispensing robot with no need for the health or home care system to provide the equipment.
• iZafe Group is strengthening its position as the leading developer of digital medication dispensing in the home by offering the first consumer version of the most convenient, safe and economical medication dispensing robot on the market to hundreds of thousands of patients, families and home health care personnel.

“For some time, we have been observing the ground-breaking work of our Italian partners to establish Sempli Farma, a service offered via pharmacies that connects treating physicians with patients and their families through a closed medication dispensing system. Dosell is a key strategic component of Sempli Farma and the time has now come for us to take the initiative and establish a similar system. The Dosell Konsument (Dosell Consumer) service will initially be launched in the Swedish market,” says Anders Segerström, CEO of iZafe Group. “We have invested during the year in product development and upgrading of Dosell and the software to adapt Dosell and the Dosell app to the consumer market, which will also be of tremendous benefit to other customers and users.”

Read more about the forthcoming launch of Dosell Consumer and pre-register for the service here.

Dosell Consumer is one component of the long-term strategy to position iZafe Group as a key player in the digitalisation of home health care. DosPac* from Apoteket AB and MinDos** from Kronans Apotek, for example, have already made it possible for anyone to get their medicines in dose-packed sachets, regardless of whether or not a doctor has prescribed the service. These services, for which the patient pays a small monthly fee, allow the patient and their relatives to decide the safest way to handle their medications.

Dosell Consumer is aimed primarily at the more than 200,000 people who already receive their medications in dose-packed sachets, as well as all of those who choose in the future to pay for medication delivered in sachets via DosPac and MinDos to enhance safety and peace of mind. Dosell Consumer will also appeal to relatives who want to make sure their loved ones take the right medicines at the right time to improve wellbeing and minimise the risk of medication errors. If the person does not take their medication as planned, the Dosell app notifies a relative or care professional, who can act quickly to make sure the medication is taken as prescribed.

Dosell Consumer will provide secure and valuable assistance to people who want to make medication handling safer while giving them more freedom and independence. This will be particularly valuable for older people and those who take multiple medications, for example. Safe and secure medication dispensing increases independence and helps make it possible for people to remain in their own homes longer.

“Dosell substantially improves patient safety because it prevents the user from taking the wrong medicine or missing a dose. We believe this will be hugely appreciated by people who want to offer the service to their parents and other relatives. Users will no longer have to arrange their days around home care visits and can live their lives more freely,” concludes Anders Segerström, CEO of iZafe Group.

In pace with the digitalisation of health care, iZafe Group is setting a new standard for digital dose-packed dispensing in the home that is making digital medication dispensing available to everyone who wants to create a safe and secure setting for medication dispensing.

With products like Dosell Consumer and future patents, iZafe Group is poised to revolutionise at-home care, especially for users who want to live independently at home for longer, but with the peace of mind that comes with knowing relatives and care professionals can step in if something goes wrong.

About Dosell Consumer

• Dosell Consumer and the Dosell app are a niched version of iZafe’s professional solution, adapted so that that users and relatives can administer and ensure the right medication themselves, without being dependent on care professionals.
• Alarms can be sent to up to three recipients. The associated app has been adapted and gives the user control over settings including the following:
• The exact time that medicine can be taken and whether it can be dispensed before the scheduled time. Dispensing earlier than prescribed should always be approved by the treating physician before the intake time is changed.
• Administration of the individuals who will be recipients of alarm events.
• When and how alarms are sent via SMS to recipients with a warning that scheduled medicine has not been taken out of Dosell.
• Dosell Consumer has a dedicated app with a simpler, adapted design for consumer use. The app is compatible with all smart phones and can be downloaded from Google Play and the Apple App Store.
• Dosell Consumer will be available from sources including pharmacies, local medical centres and partners, as well as via www.dosell.com.
• Dosell Consumer is a subscription service.
• Others, such as relatives, can sign up and pay for the Dosell Consumer subscription on behalf of the user.
• As previously communicated, iZafe Group has a patent pending, which provides important protection for the company’s further development of Dosell as a digital platform. Dosell Consumer is yet another strategic step towards achieving the vision of “The digital ward in the home”.
• Dosell Consumer will be available for delivery in the second quarter of 2021, but interested consumers can already sign up to ensure access when Dosell Consumer is launched.

Read more about the forthcoming launch of Dosell Consumer and pre-register for the service here.

Do you work in health care or home care?
If you who work in health care or other professional home service provision and would like to know more about how you can work with and offer Dosell in your organisation, please contact:

Tobias Johansson
Sales Manager
iZafe Group AB (publ)
+46 72-567 73 61

About dose-packed sachets from Apoteket AB and Kronans Apotek

*DosPac
Do you or a relative take one or more medications, perhaps at different times of the day? With Apoteket DosPac, you will receive them pre-sorted, in the correct doses and pre-packed in daily dose-packed sachets, so you no longer have to take the time to do that. Each sachet contains the medications you are supposed to take at the same time. Your personal details, the contents of the sachet and when the medication is to be taken are printed on every sachet. That gives you control over making sure you take the right dose at the right time.
Source: https://www.apoteket.se/dospac/

**MinDos
MinDos is a subscription service for dose-packaging of your medications. Instead of receiving your medications in bottles or blister packs, you receive them pre-packed in a roll of individual dose-packed sachets. Each sachet contains all the medications you are supposed to take at the same time. Your personal details, the contents of the sachet and the time each medication should be taken are printed on the sachet.
Source: https://www.kronansapotek.se/tjanster/mindos/

“We are receiving valuable ongoing feedback from pilot projects and our partners in the Nordic countries and Italy, which means we can prioritise the right issues to further improve Dosell. In the light of the feedback we have documented, the past six months have been a period of intense development and investments in products, technology and software. IZafe group is reinforcing its leading position in a powerfully growing market through ongoing investments in products and the market, combined with close cooperation with partners,” says Anders Segerström, CEO of iZafe Group.

The sale of the company’s security business, iZafe Security, created the necessary scope for continuous investments in product development and commercialisation of Dosell. The company has released numerous new features in pace with several public procurement processes and the launch of additional pilot projects. In parallel, the partner network has been expanded and international establishment is growing.

A selection of recently developed new or updated features:

• A new safety feature that provides the option to dispense dose-packed sachets using the “wait until button is pressed” has been launched.
  • When it is time to dispense medication, the user must press the button to get the medicine. If they do not press the button within a predetermined time, the medication is locked inside Dosell.
• A demo mode has been developed and introduced to make it easier to present Dosell’s features and alarm handling at training sessions, for example.
• The option to dispense dose-packed sachets at non-scheduled times makes the system more flexible for users, so that Dosell adjusts to their daily routines and not the reverse.
• A feature for accessing information about when the next dose will be dispensed.
• Improved handling of minutes in OCR.
• The red LED light that shines in the dose compartment when the user has not removed the sachet in time goes out automatically when the sachet is removed. In the past, the user had to press a button to turn off the light. 
• Validation of Finnish dose-packed sachets.
• The company has invested in and developed software and systems, including other functionalities to improve how Dosell communicates with the server, making easier to support and facilitate the work of partners.
• A feature to determine whether the placement of the dispensing robot should be changed to improve coverage.
• Medication dispensing robots with built-in rechargeable batteries and 48-hour battery backup will be launched early next year to further enhance safety.
• A simplified start-up process for new users to connect to Dosell will be launched in Q1 2021.

The results of the pilot project will be used as decision input for a future commercial arrangement based on an integrated solution involving automated dispensing of medication in dose-packed sachets from dispensing robots. The goal is to create a full-coverage solution for users while reducing the need for home health visits in connection with taking medication.

“We are proud of the partnership and are looking forward to working with Vivago to further develop the industry in Finland. In the first stage, we will perform a joint market analysis to build knowledge about the Finnish market. We are especially pleased that our partnership has already resulted in a strategically important pilot project.” comments Anders Segerström CEO, iZafe Group.

Major training initiatives were carried out in the autumn to prepare for the pilot project, which is expected to begin immediately after the end of the year. Twenty people will be using Dosell to manage their medication during the pilot project.

“We are delighted by the partnership between Vivago and iZafe. The partnership will be a key step in Vivago’s future ventures in the digitalisation of medication dispensing in Finland while reinforcing our service offering. The partnership with iZafe and their Dosell digital medication dispenser makes a more comprehensive service offering to our customers in Finland possible. Vivago’s health and well-being solutions combined with Dosell will enhance safety and provide better care to our elderly people.” Says Niina Vilkas, CEO Vivago Ltd.

About Vivago
Vivago develops smart safety and wellbeing solutions for preventive care by monitoring users’ health status in real-time and wellbeing 24/7. The Vivago solution includes all features required for nurse call systems and covers the entire chain of care from home care and assisted living to rehabilitation centres and hospitals. More than 100,000 people use Vivago solutions every single day. Full digitalisation of health status monitoring is opening a revolutionary path to changing care delivery from reactive to preventive while tailoring entirely patient-centred and results-driven care.

Please send your questions to  before 17:00 (5 p.m.) CET on November 10, 2020. You can also use an online form to send your questions. This form is available on iZafe's website, Investor Relations page.

The current patent application could provide the company with future patents in a large number of countries including Sweden, other parts of Europe and the USA. The fact that iZafe has a patent pending already in itself affords important protection for the company’s further development of Dosell as a digital platform and additionally strengthens iZafe’s position in the market.

“The digitalization of healthcare has accelerated in recent years, and iZafe is a leading provider of medication dose dispensing for those who want to manage their medication themselves. By protecting the further development of Dosell into a digital hub for a future digital clinic in the home, we are strengthening our position as well as our patent portfolio,” says Anders Segerström, CEO of iZafe Group.

The patent application relates to the development of a system for dispensing medication via the Dosell robot in which the dose of medication dispensed is adjusted based on current patient-specific information.

“We are convinced that the ecosystem that Dosell provides via medication dispensing and the SaaS-based services is just the start of a rapid digitalization of many measurements that can be monitored by the doctor responsible for the patient via the Dosell app. The fact that we now have a patent pending in this area is an important part of our long-term strategy for positioning iZafe as a leading player in the digitalization of home and remote healthcare. Publication of the patent application that was filed 18 months ago strengthens our position in the market while also protecting us from competitors,” says Anders Segerström.

Future digital care in the home
We are living longer and longer, and an aging population increases the need for care and social services. Society aims to deliver increasing quality for our seniors and an important part of this ambition is to offer an increasing level of care in the home. iZafe’s vision of a “digital clinic in the home” will only be possible if important information about the patient’s state of health can be measured and communicated to the treating doctor.

This further development of Dosell allows sensors in the home to take the patient’s readings and communicate these via iZafe’s cloud-based solution. The treating doctor can then make sure that the correctly adjusted dose is always given to the patient via Dosell. The new technology further increases patient safety in respect of the dosing and dispensing of medication. Using Dosell as a hub realizes the vision of a digital doctor’s round in the home, which will be particularly important for patients being treated for conditions such as dementia, complex heart problems, diabetes, Parkinson’s and MS.

“Through Dosell, iZafe has already set a new standard for digital medication dispensing and future patents will enable the company to revolutionize care – above all in the home and especially for seniors, people with multiple conditions and patients on multiple medications,” says Dr Göran Sjönell, doctor in general medical practice, co-founder of iZafe Group and inventor of Dosell.